BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration’s (FDA) newly announced plan to reduce reliance on ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Emulate, Inc. today announced that it recently formed a research collaboration with Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson ...
Learn how Organ-on-a-Chip technology supports human-relevant preclinical research and how Liver-Chip models can improve ...
Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance ...
Historical data indicate that animal models are not ideal for the determination of the efficacy and safety of human therapeutics. Ninety percent of drugs that pass animal studies do not receive ...
In April 2025, the U.S. Food and Drug Administration (FDA) released a strategic roadmap to make animal testing the exception for preclinical safety and toxicity studies within the next three to five ...
Researchers are increasingly turning to organ-on-a-chip technology for drug testing and other applications. In a clean room in his lab, Sean Moore peers through a microscope at a bit of intestine, its ...
insights from industryJim CorbettCEOEmulate, Inc. In this interview, NewsMedical speaks with Jim Corbett, CEO of Emulate, Inc., about the development and impact of the AVA Emulation System and how it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results